These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23603933)

  • 1. Stimulation of metabotropic glutamate (mGlu) 2 receptor and blockade of mGlu1 receptor improve social memory impairment elicited by MK-801 in rats.
    Hikichi H; Kaku A; Karasawa J; Chaki S
    J Pharmacol Sci; 2013; 122(1):10-6. PubMed ID: 23603933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
    Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
    J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate receptors regulate cortical gamma hyperactivities elicited by ketamine in rats.
    Hiyoshi T; Hikichi H; Karasawa J; Chaki S
    Neurosci Lett; 2014 May; 567():30-4. PubMed ID: 24680852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Face-washing behavior induced by the group I metabotropic glutamate receptor agonist (S)-3,5-DHPG in mice is mediated by mGlu1 receptor.
    Hikichi H; Iwahori Y; Murai T; Maehara S; Satow A; Ohta H
    Eur J Pharmacol; 2008 May; 586(1-3):212-6. PubMed ID: 18378225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
    Galici R; Echemendia NG; Rodriguez AL; Conn PJ
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological effects of metabotropic glutamate receptor ligands on prepulse inhibition in DBA/2J mice.
    Hikichi H; Nishino M; Fukushima M; Satow A; Maehara S; Kawamoto H; Ohta H
    Eur J Pharmacol; 2010 Aug; 639(1-3):99-105. PubMed ID: 20371235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test.
    Fukumoto K; Iijima M; Chaki S
    Psychopharmacology (Berl); 2014 Jun; 231(11):2291-8. PubMed ID: 24402133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of the metabotropic glutamate (mGlu) 2 receptor attenuates the MK-801-induced increase in the immobility time in the forced swimming test in rats.
    Kawaura K; Karasawa J; Hikichi H
    Pharmacol Rep; 2016 Feb; 68(1):80-4. PubMed ID: 26721357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice.
    Molinaro G; Traficante A; Riozzi B; Di Menna L; Curto M; Pallottino S; Nicoletti F; Bruno V; Battaglia G
    Mol Pharmacol; 2009 Aug; 76(2):379-87. PubMed ID: 19439499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.
    Marek GJ; Wright RA; Schoepp DD; Monn JA; Aghajanian GK
    J Pharmacol Exp Ther; 2000 Jan; 292(1):76-87. PubMed ID: 10604933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors.
    Gewirtz JC; Chen AC; Terwilliger R; Duman RC; Marek GJ
    Pharmacol Biochem Behav; 2002 Sep; 73(2):317-26. PubMed ID: 12117585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.
    Pitsikas N; Markou A
    Neuropharmacology; 2014 Oct; 85():27-35. PubMed ID: 24859609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.
    Koike H; Iijima M; Chaki S
    Neuropharmacology; 2011 Dec; 61(8):1419-23. PubMed ID: 21903115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mGluR
    Sokolenko E; Hudson MR; Nithianantharajah J; Jones NC
    J Psychopharmacol; 2019 Dec; 33(12):1588-1599. PubMed ID: 31580222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
    Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
    J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine in combination with metabotropic glutamate receptor antagonists on schedule-controlled responding and thermal nociception.
    Fischer BD; Zimmerman EI; Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 2008 Feb; 324(2):732-9. PubMed ID: 17982001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The difference in effect of mGlu2/3 and mGlu5 receptor agonists on cognitive impairment induced by MK-801.
    Vales K; Svoboda J; Benkovicova K; Bubenikova-Valesova V; Stuchlik A
    Eur J Pharmacol; 2010 Aug; 639(1-3):91-8. PubMed ID: 20371226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabotropic glutamate receptor 1 blockade impairs acquisition and retention in a spatial Water maze task.
    Steckler T; Oliveira AF; Van Dyck C; Van Craenendonck H; Mateus AM; Langlois X; Lesage AS; Prickaerts J
    Behav Brain Res; 2005 Oct; 164(1):52-60. PubMed ID: 16043241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic profiles of TASP0443294, a novel and orally active positive allosteric modulator of metabotropic glutamate 2 receptor.
    Hikichi H; Hiyoshi T; Marumo T; Tomishima Y; Kaku A; Iida I; Urabe H; Tamita T; Yasuhara A; Karasawa J; Chaki S
    J Pharmacol Sci; 2015 Mar; 127(3):352-61. PubMed ID: 25837934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039).
    Rorick-Kehn LM; Johnson BG; Burkey JL; Wright RA; Calligaro DO; Marek GJ; Nisenbaum ES; Catlow JT; Kingston AE; Giera DD; Herin MF; Monn JA; McKinzie DL; Schoepp DD
    J Pharmacol Exp Ther; 2007 Apr; 321(1):308-17. PubMed ID: 17204749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.